These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 37697)

  • 21. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
    Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
    J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
    J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.
    Cantillon M; Prakash A; Alexander A; Ings R; Sweitzer D; Bhat L
    Schizophr Res; 2017 Nov; 189():126-133. PubMed ID: 28215471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-acting neuroleptics. IV. Preliminary study of clopimozide (R 29764)].
    Bobon J; Parent M; Toussaint C; Pinchard A
    Acta Psychiatr Belg; 1976; 76(1):138-43. PubMed ID: 970182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [7 years of experience with delayed action neuroleptics].
    Noguera Hosta R; Rendueles de Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
    [No Abstract]   [Full Text] [Related]  

  • 31. A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
    Meltzer HY; Lindenmayer JP; Kwentus J; Share DB; Johnson R; Jayathilake K
    Schizophr Res; 2014 Apr; 154(1-3):14-22. PubMed ID: 24630262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of bromperidol in an open study].
    Hucker H
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
    [No Abstract]   [Full Text] [Related]  

  • 33. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs.
    Freedman R; Kirch D; Bell J; Adler LE; Pecevich M; Pachtman E; Denver P
    Acta Psychiatr Scand; 1982 Jan; 65(1):35-45. PubMed ID: 6138923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study using double-blind method of sultopride and thioproperazine].
    Sizaret P; Moreau C
    Encephale; 1977; 3(2):111-20. PubMed ID: 19230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 40. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.